[ad_1]
Highlights
- Nuvo Group has saved the value vary of its extraordinary shares between US$ 14 to US$ 16 per share.
- Nuvo IPO is attracting buyers’ consideration as it’s planning to go public on the NYSE.
- The healthcare firm is trying to generate gross proceeds and use them to fund analysis and improvement actions.
Nuvo Group Ltd., a being pregnant care administration firm has caught the eye of buyers in North American markets after it lately introduced phrases for its preliminary public providing (IPO) plans.
Nuvo is concerned within the improvement of a distant platform to allow folks to get entry to medical-grade knowledge within the being pregnant care ecosystem.
Nuvo Group has saved the value vary of its extraordinary shares between US$ 14 to US$ 16 per share. If the shares are offered at US$ 15 apiece, then Nuvo will obtain round US$ 16.3 million in gross proceeds.
Additionally Learn: Is Zegna publicly traded? How to buy ZGN stock?
Additionally, if the underwriters train their choice to purchase extra shares, then the gross proceeds are anticipated to extend as much as US$ 17.7 million.
Nuvo IPO: Key particulars
Based on the funding prospectus filed with the US Securities and Alternate Fee, the being pregnant care platform is trying to promote 666,667 shares by the preliminary public providing.
Nuvo needs to make its public debut on the New York Stock Exchange (NYSE) and has utilized to get NUVO as its inventory image. Buyers who need to purchase the NUVO inventory should await the healthcare firm to go public because it continues to stay non-public.
© 2021 Kalkine Media®
You should buy the inventory after it begins buying and selling on the NYSE or discover out a buying and selling platform of a brokerage firm that’s permitting retail buyers to register to pay money for the pre-IPO inventory.
The healthcare firm is trying to generate gross proceeds and use them to fund analysis and improvement actions for its INVU platform.
Backside line
Nuvo has lately commercialized the INVU platform, and it’s a hybrid {hardware} and software program system. INVU supplies distant entry to all stakeholders within the being pregnant care market.
The Israel-based firm has obtained clearance by the Food and Drug Administration (FDA) for restricted monitoring capabilities.
Based on the Knowledge Bridge Market Analysis report, the worldwide being pregnant market is predicted to register progress between 2021 to 2028 and through this era, this market will register a compound annual growth rate (CAGR) of 5.3 per cent.
Additionally Learn: Sidus Space IPO: How to buy this aerospace stock in Canada?
$(document).ready(function() $('[data-toggle="popover"]').popover( trigger: "manual", html: true, animation: false, content:function() //return $('#popover-content').html(); return $($(this).attr('data-id')).html();
) .on("mouseenter", function() var _this = this; $(this).popover("show"); $(".popover").on("mouseleave", function() $(_this).popover('hide'); ); ).on("mouseleave", function() var _this = this; setTimeout(function() if (!$(".popover:hover").length) $(_this).popover("hide");
, 300);
);
var $window = $(window);
$window.scroll(function()
var scroll = $window.scrollTop();
var winheight = $(window).height();
var documentheight = $(document).height();
var postcontent = $(".entry-content").height();
var post_side = $("#post_side").height();
var footer__widgets = $(".footer--dark").height();
var footersection=footer__widgets+post_side;
var footersectionmin=documentheight-(footer__widgets+post_side)-300;
if(postcontent>=1020 && (scroll >= 1020 && scroll<=footersectionmin) )
$("#post_side").addClass("lead-generation-style");
else
$("#post_side").removeClass("lead-generation-style");
);
$('.post-content-height img').on('click', function ()
var image = $(this).attr('src');
console.log(image);
$("#postContentImage").attr("src", image);
$('#imageModal').modal('show');
);
);
function shareButton(type){
if(type == 'facebook')
// window.open(facebook,'facebook-share-dialog',"width=626, height=436");
$(document).ready(function()
$.ajaxSetup( cache: true );
$.getScript('//connect.facebook.net/en_US/sdk.js', function()
FB.init(
appId: '633927664153511',
version: 'v2.7'
);
// $('#loginbutton,#feedbutton').removeAttr('disabled');
// FB.getLoginStatus(updateStatusCallback);
FB.ui(
method: 'share',
href: "https://kalkinemedia.com/ca/news/ipo/nuvo-ipo-how-to-buy-this-pregnancy-care-platforms-stock",
// href:"https://kalkinemedia.com/podcast/kalkine_weekly",
, function(response)
console.log(response);
// Script after Sharing
);
);
);
if(type == 'instagram')
window.open(instagram,'facebook-share-dialog',"width=626, height=436");
if(type == 'twitter')
window.open(twitter,'facebook-share-dialog',"width=626, height=436");
if(type == 'linkedin')
window.open(linkedin,'facebook-share-dialog',"width=626, height=436");
}
[ad_2]
Source link
